Theme: Theme: A Global Discussion on technologies, advances and challenges in Vaccines and Clinical Trials for Covid-19
- Vaccine and Clinical Trials
- Vaccines Congress-2022
- Sessions and Tracks
- Market Analysis
- VISA-Trip Advisor
November 04- November 05, 2022 | Toronto, Canada
Conference Series LLC Ltd welcomes you to attend the 34th Annual Congres on Vaccine and Clinical Trials to be held in Toronto, Canada on November 04-05, 2022. The theme for the conference is Harnessing the Global Innovations in vaccines, Therapeutics and Healthcare for the better future.
Details of Vaccines Congress-2022 Conferences in Canada
|November 04-05, 2022
- Principal Investigators
- Medical Directors
- Directors/Executive Directors
- Vice Presidents/Senior Vice Presidents/Executive Vice Presidents
- Deans/Senior Professors/Associate Professor/Assistant Professors
- Research Scholars
- Business Entrepreneurs
- Medical Devices Manufacturing Companies
- Vaccine Manufacturing Companies
- Vaccine Developers and Investigators
- The advantages of the Speaker and abstract pages are created in Google on your profile under your name would get worldwide visibility.
- Our comprehensive online advertising attracts 30000+ users and 50000+ views to our Library of Abstracts, which takes researchers and speakers to our conference.
- Meet with hundreds of like-minded experts who are pioneers in Vaccines and share ideas.
- All participants in the conference would have a different reason to participate with eminent speakers and renowned keynote speakers in one-to-one meetings.
- A rare opportunity to listen what the world's experts are learning about from the world's most influential researchers in the area of Vaccines and Clinical Trails at our Keynote sessions.
- Vaccines intensive conference schedule, you will acquire experience and expertise in strategic gift preparation that is worth its weight golf, forming an impressive array of recognised professionals.
- Best Poster Award nominations.
- Award for Outstanding Young Researcher.
- Group Registration Advantages.
- Worldwide appreciation of the profile of Researchers.
- Obtain credits for professional growth.
- Explore the latest of cutting edge analysis.
- Make long-term bonds at social and networking activities.
- An ability to advertise one page in the distribution of abstract books and flyers that ultimately gets 1 million views and adds great value to your research profile.
- Learn a transition beyond your area of interest to learn more about new subjects and studies away from your core subject of Vaccines and Clinical Trials.
- We have distinctive networking, learning and enjoyable integration into a single package.
- Each speaker has the separate Speaker profile.
- Professional Development-Improve understanding and knowledge.
- Attendance at conference supports, rejuvenates and energises delegates.
- Your involvement in our conference will help with a new methodology and ideology that can be used to broaden the outcomes of businesses or industries.
- Opportunities for Vaccines researchers and experts in the same field to meet and exchange new ideas through an conference.
- Exposure to the international environment would increase the possibility of new companies.
- Opportunity to demonstrate your company's latest technologies, new products, or service your business to a wide range of international participants.
- Increase business by our conference participants through lead generation.
- It takes a lot of time, effort and drive to create a successful company, so it's always nice to have a network of colleagues and associates to draw energy from individuals who share a common drive and objective.
- Conferences in vaccines provide opportunities for more attention and contemplation that could help you move your company to the next stage.
- Benchmarking main organization plans and moving it forward.
- Get feedback from trustworthy people at our conference to your company questions and challenges.
- On our conference banner, website and other proceedings, branding and marketing content, the advertising logo of your company.
- Nobody has this massive visitors to Vaccines and Clinical Trials in the world, this is the best forum to highlight society.
- Creating long-lasting peer relationships.
- In our conference banner, website and other proceedings, branding and marketing material, promotional content and your Organization logo will increase your number of subscribers/members by 40%.
- The exposure of our event to your Company listing in the Global Business forum will have a great effect on your association.
- Your representatives can network to update their knowledge and understanding of your organisation and services with key conference delegates.
- Vaccines advertising materials such as posters, brochures, pamphlets, services that will be circulated to hospitals, universities, society and researchers will be integrated with information.
Cancer vaccines are a form of immunotherapy that can help educate the immune system about what cancer cells “look like” so that it can recognize and eliminate them.
Vaccines have proven effective in preventing diseases caused by viruses and bacteria. Since the first vaccine was developed more than 200 years ago, they have prevented some of the twentieth century’s deadliest diseases and have helped save hundreds of millions of lives globally.
In the case of diseases caused by viruses (e.g., measles, polio, and smallpox) and bacteria (e.g., diphtheria, tetanus, and tuberculosis), vaccines work by exposing people to a weakened or inactivated version of the threat. This enables their immune system to identify these threats according to their specific markers—known as “antigens”—and mount a response against them. These vaccines typically work best in the preventive setting, when an individual is given the vaccine before being infected by the bacteria or virus.
In the case of cancer, however, the situation is more complicated for several reasons (more below) and this has made it more difficult to develop vaccines to either prevent or treat cancer. In particular, unlike bacteria and viruses, which appear foreign to our immune system, cancer cells more closely resemble our normal, healthy cells. Furthermore, each individual’s tumor is in some sense unique and has its own distinguishing antigens. As a result, more sophisticated approaches are necessary to develop effective cancer vaccines.
- Preventive Cancer Vaccines
- Therapeutic Cancer Vaccines
- Personalized Neoantigen Vaccines
Preventive Cancer Vaccines:
Viral infections are responsible for the development of several cancers and preventive vaccines play an important role in reducing risk. For instance, cervical cancer and head and neck cancer can be caused by human papilloma virus, or HPV, whereas liver cancer can be caused by hepatitis B virus or HBV. Several vaccines have been developed that can prevent HBV and HPV infection and, as a result, protect against the formation of HBV- and HPV-related cancers.
Four of these preventive cancer vaccines have been approved by the U.S. Food and Drug Administration (FDA).
Therapeutic Cancer Vaccines:
Each individual’s tumor is in some sense unique and has its own distinguishing antigens. As a result, more sophisticated cancer vaccine approaches are necessary. Fortunately, doctors can now identify targets on patients’ tumors that can help distinguish cancer cells from their normal cells. Sometimes these targets are normal proteins that are produced at abnormally high levels by cancer cells, such as prostatic acid phosphatase (PAP), which is often overexpressed by prostate cancer cells. Taking advantage of that insight, the sipuleucel-T vaccine was developed and received FDA approval in 2010 for the treatment of patients with advanced prostate cancer. Additionally, virus-derived proteins expressed by virus-infected cancer cells offer another promising source of markers that can be targeted through vaccines. Another exception is Bacillus Calmette-Guérin, or BCG, a tuberculosis vaccine that acts as a general immune stimulant. In 1990, BCG became the first immunotherapy of any type to be approved by the FDA and is still used for the treatment of early-stage bladder cancer.
- Vaccine and Vaccination
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- Cancer Vaccines
- Toxoid Vaccines
- DNA, RNA & Synthetic Vaccines
- Vaccines for Pregnant Women
- Travel medicine and vaccines
- Zika Virus Vaccines
- Vaccines for Unconventional Diseases
- Vaccine Production & Development
- Human Vaccines Against Infectious Diseases
- Combination & Conjugate Vaccines
- Vaccine Safety & Efficacy
- HIV, Malaria & TB Vaccines
- RDT in Antibiotic Research
- Side-effects of Vaccines
- Vaccines Manufacturing Technologies
- New Trends in Vaccines Development
- Vaccines Research and Clinical Trails
To share your views and research, please click here to register for the Conference.